Cellectar Biosciences Logo
US15117F8804
A41BQ3

Cellectar Biosciences

Loading quotes...

Forecast

The analysts' average price target is €10.02 (+1,107.23%). The median is €10.02 (+1,107.23%).

Buy
  7
Hold
  1
Sell
  0

Discussions in the community

There is no discussion about this asset yet.

Start discussion

There is currently no news available for this company. We are working on adding more providers to change this.

Financials

In the last quarter, Cellectar Biosciences had revenue of €0 and net profit of -€7.04m
(EUR) September 2026
YoY
Revenue 0 -
Gross profit -31.14k -
Net profit -7.04m 85.92%
EBITDA -7.15m 91.19%

Fundamentals

Metric Value
Market capitalization
€8.41m
Number of shares
10.04m
52-week high/low
€4.28 - €0.82
Dividends No
Beta
0.58
P/E ratio
-0.25
PEG ratio
0.00
P/B ratio
0.72
P/S ratio
0.00

Company profile

Name
Cellectar Biosciences
CEO
James V. Caruso
Headquarters Florham Park, nj
USA
Website
Sector
Materials
Industry
Chemicals
Employees 11
🍪

Parqet  uses cookies. Learn more